Statement of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Jun. 30, 2018	$ 227	$ 3,459	$ 101,352,724	$ (83,692,146)	$ 17,664,264
Balance (in shares) at Jun. 30, 2018	226,570	3,458,587
Series A Preferred stock issued for employee stock compensation	$ 27		55,001		55,027
Series A Preferred stock issued for employee stock compensation (in shares)	26,636
Common stock issued for consulting and legal services rendered		$ 10	79,450		79,460
Common stock issued for consulting and legal services rendered (in shares)		9,576
Stock options issued for compensation			11,920		11,920
Warrants issued to Scientific Advisory Board	$ 0	$ 0	1,543	0	1,543
Common shares issued for Directors fees		$ 1	7,499		7,500
Common shares issued for Directors fees (in shares)		966
Net loss				(1,841,463)	(1,841,463)
Balance at Sep. 30, 2018	$ 254	$ 3,470	101,508,137	(85,533,609)	15,978,251
Balance (in shares) at Sep. 30, 2018	253,206	3,469,129
Balance at Jun. 30, 2018	$ 227	$ 3,459	101,352,724	(83,692,146)	17,664,264
Balance (in shares) at Jun. 30, 2018	226,570	3,458,587
Net loss					(4,072,455)
Balance at Dec. 31, 2018	$ 254	$ 3,476	101,601,431	(87,764,601)	13,840,559
Balance (in shares) at Dec. 31, 2018	253,592	3,457,070
Balance at Sep. 30, 2018	$ 254	$ 3,470	101,508,137	(85,533,609)	15,978,251
Balance (in shares) at Sep. 30, 2018	253,206	3,469,129
Series A Preferred stock issued for employee stock compensation			53,621		53,621
Series A Preferred stock issued for employee stock compensation (in shares)	386
Common stock issued for consulting and legal services rendered		$ 4	26,996		27,000
Common stock issued for consulting and legal services rendered (in shares)		4,198
Warrants issued to Scientific Advisory Board			1,429		1,429
Common shares issued for Directors fees		$ 2	11,248		11,250
Common shares issued for Directors fees (in shares)		1,743
Net loss				(2,230,992)	(2,230,992)
Balance at Dec. 31, 2018	$ 254	$ 3,476	101,601,431	(87,764,601)	13,840,559
Balance (in shares) at Dec. 31, 2018	253,592	3,457,070
Balance at Jun. 30, 2019	$ 256	$ 3,845	102,712,845	(92,116,586)	10,600,360
Balance (in shares) at Jun. 30, 2019	255,714	3,844,921
Series A Preferred stock issued for employee stock compensation	$ 0	$ 0	51,398	0	51,398
Series A Preferred stock issued for employee stock compensation (in shares)	387	0
Common stock issued for consulting and legal services rendered		$ 6	26,994		27,000
Common stock issued for consulting and legal services rendered (in shares)		6,201
Warrants issued to Scientific Advisory Board			908		908
Common shares issued for Directors fees		$ 3	11,247		11,250
Common shares issued for Directors fees (in shares)		2,553
Net loss				(1,561,133)	(1,561,133)
Balance at Sep. 30, 2019	$ 256	$ 3,854	102,803,392	(93,677,719)	9,129,783
Balance (in shares) at Sep. 30, 2019	256,101	3,853,675
Balance at Jun. 30, 2019	$ 256	$ 3,845	102,712,845	(92,116,586)	10,600,360
Balance (in shares) at Jun. 30, 2019	255,714	3,844,921
Net loss					(3,488,659)
Balance at Dec. 31, 2019	$ 366	$ 3,871	103,323,412	(95,605,245)	7,722,404
Balance (in shares) at Dec. 31, 2019	366,488	3,870,572
Balance at Sep. 30, 2019	$ 256	$ 3,854	102,803,392	(93,677,719)	9,129,783
Balance (in shares) at Sep. 30, 2019	256,101	3,853,675
Series A Preferred stock issued for employee stock compensation			49,394		49,394
Series A Preferred stock issued for employee stock compensation (in shares)	387
Series A Preferred Stock issued for accounts paayble-related party	$ 100		392,569		392,669
Series A Preferred Stock issued for accounts payable-related party (in Shares	100,000
Series A Preferred Stock issued for loan origination fee	$ 10		39,291		39,301
Series A Preferred Stock issued for interest (in shares)	10,000
Common stock issued for consulting and legal services rendered		$ 12	26,988		27,000
Common stock issued for consulting and legal services rendered (in shares)		11,932
Warrants issued to Scientific Advisory Board			533		533
Common shares issued for Directors fees		$ 5	11,245		11,250
Common shares issued for Directors fees (in shares)		4,965
Net loss				(1,927,526)	(1,927,526)
Balance at Dec. 31, 2019	$ 366	$ 3,871	$ 103,323,412	$ (95,605,245)	$ 7,722,404
Balance (in shares) at Dec. 31, 2019	366,488	3,870,572